EXOCRINE PANCREATIC ADENOCARCINOMA
Clinical trials for EXOCRINE PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new EXOCRINE PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for EXOCRINE PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise in early cancer trial
Disease control Recruiting nowThis early-stage trial tests a new drug, sigvotatug vedotin, in people with advanced solid tumors like lung, head and neck, and breast cancers. The study aims to find the safest dose and check for side effects, both when the drug is used alone and with other cancer treatments. Ab…
Matched conditions: EXOCRINE PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Jun 18, 2026 11:47 UTC
-
Pancreatic cancer study digs into tumor DNA to unlock clues
Knowledge-focused Recruiting nowThis study looks at tumor samples from 300 people with exocrine pancreatic cancer to find links between genetic changes in the tumor and how the disease behaves. Researchers will use advanced DNA sequencing to analyze samples already collected from surgeries and biopsies. The goa…
Matched conditions: EXOCRINE PANCREATIC ADENOCARCINOMA
Sponsor: Centre Leon Berard • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:09 UTC